Print
Detailed Quote
Listen
|
Refer Friends and Family Today and Share the Benefits of Fidelity.
Snapshot:NVS
NOVARTIS AG
98.95
-0.09 (-0.09 %)as of 4:02:02pm ET 03/05/2015
|
||||||||||||||||||||||||||||||||||||||
News & EventsLog in for more news
Events
Company ProfileLog in for more informationNovartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, such as oncology, cardio-metabolic, immunology… 
View more
Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, such as oncology, cardio-metabolic, immunology and dermatology, retina, respiratory, neuroscience, and established medicines. The company's Alcon division provides various eye care products, including surgical, ophthalmic pharmaceuticals, and vision care products; ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers generic pharmaceuticals comprising active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates primarily antibiotics; protein or biotechnology-based products; and cytotoxic products for the hospital market, as well as biotech manufacturing services to other companies. The company distributes its OTC products through various channels, such as pharmacies, food, drug, and mass retail outlets. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland. 
View less
Sector (GICS®)Health CareIndustry (GICS®)PharmaceuticalsEnvironmental, Social & Governance Summary (ESG)
ESG ratings enable you to leverage independent ESG research to evaluate how companies are managing ESG risks and addressing ESG opportunities. Learn more Accounting & Governance Risk Score (AGR®)
The GMI Accounting and Governance Risk (AGR®) Score & Rating is widely recognized as an indicator of the confidence level surrounding a company's management and reported financials. Learn more About Environmental, Social & Governance Summary (ESG)GMI ESG RatingsEnvironmental, Social, and Governance (ESG) Flags: GMI Ratings publishes Environmental, Social and Governance (ESG) ratings on over 6,000 companies worldwide. These ratings provide an independent assessment of the sustainable investment value of public companies. The ESG Ratings model is based on a carefully crafted and applied list of KeyMetrics® that result in an overall ESG concern level as expressed by Red (High Concern), Yellow (Average Concern), and Green (Low Concern) flags. Unlike traditional ESG risk models, GMI's rating methodology is designed to identify risks most likely to affect equity valuations. Specifically, these ratings reflect actual corporate behaviors rather than policies or affirmations of intent to adhere to best ESG practices. Further, unlike other models with evenly weighted metrics, we assign context-sensitive relative weightings to our key metrics, based on market, regional, ownership or sector differences. Individual company scores are then assigned as a percentile rank, ranging from 1 (worst ranked) to 100 (best) on the basis of these KeyMetrics® and then converted to the Red, Yellow or Green flag designation. Company Reports: In addition to a company's overall risk rating, ESG reports also include an industry rating based on a comparison between the company's risk levels in each ESG component area relative to its industry peers. Further, the ESG analysis serves as a summary of behavioral events that contributed to the company's overall risk level. GMI Accounting and Governance Risk (AGR) Score & RatingThe GMI Accounting and Governance Risk (AGR) Score & Rating is widely recognized as an indicator of the confidence level surrounding a company's management and reported financials. Scores range from 0 to 100, and correspond to a risk classification for each company ranging from "Very Aggressive" to "Conservative." The AGR Score is a percentile ranking among the approximately 8,000 companies rated by GMI. Through continued back-testing, GMI has demonstrated a strong correlation between its quarterly AGR Score and the likelihood of adverse events, including securities class action litigation, financial restatements, regulatory enforcement actions, and stock price declines. Thus, a company's AGR Score can help investors looking to manage risk or enhance investment performance. GMI forensically analyzes the financial reporting and governance practices of over 8,000 North American-based publicly traded companies. About GMIGMI is an independent risk research firm which provides a statistically modeled assessment of corporate integrity. Founded in 2002 in direct response to the growing number of scandals, lawsuits and investor losses resulting from fraudulent corporate behavior, the firm identifies potential high-risk company accounting and governance activity, which in turn has been historically correlated to stock price declines, securities class-action litigation, and material financial restatements. The product of GMI's analysis is a unique risk measure - the AGR Score which can be used by investors as a way to more effectively manage corporate risk. Full Time Employees: 133,413
Executives
www.novartis.com
Lichtstrasse 35 1-41 61 324 11 11 |
Analyst OpinionsThe Equity Summary Score is an accuracy-weighted sentiment derived from the ratings of independent research providers on Fidelity.com. It uses the past relative accuracy of the providers in determining the emphasis placed on any individual opinion. Learn More.... Log in to view the Equity Summary Score for NVS
Log in
to view all Analyst Opinions for NVS
Research Reports
Company Research Highlights® Report (PDF)
|
| NVS | Industry Average | Percentile in Industry | |
|---|---|---|---|
| Market Capitalization | $237.56B | $36.67B | 100th |
| Total Return (1 Year Annualized) | 23.25 | 16.79 | -- |
| Beta (1 Year Annualized) | 0.57 | 0.69 | 22nd |
EPS (TTM) | $4.31 | $2.70 | 97th |
| Current Consensus EPS Estimate | $1.07 | -- | -- |
| EPS Growth (TTM vs. Prior TTM) | 16.13% | +13.86% | 66th |
| P/E (TTM) | 22.93 | 27.13 | 36th |
| Dividend Yield (Annualized) | 2.84% | 3.09% | 69th |
| Total Revenue (TTM) | $52.42B | $36.38B | 99th |
| Revenue Growth (TTM vs Prior TTM) | +0.63% | +9.08% | 37th |
| Shares Outstanding | 2,398,626,000 | 2,350,356,224 | 97th |
| Shares Short* | 2.50M | -- | -- |
| Institutional Ownership | 9.85% | 44.97% | 27th |
* Short Interest data provided by NASDAQ, NYSE, or AMEX and is updated periodically and on a bi-monthly basis (depending on the listing exchange).
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.
Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.
Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.
News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.